Trial
NCT02048943
Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Roswell Park Cancer Institute
Collaborators
National Cancer Institute (NCI); Novartis
Condition
Duct Cell Adenocarcinoma of the Pancreas
Intervention
dovitinib lactate
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-01-09